Open Access
MATEC Web of Conferences
Volume 5, 2013
REMCES XII – XIIe Rencontre Marocaine sur la Chimie de l'État Solide
Article Number 04030
Number of page(s) 3
Section Poster Communications
Published online 09 September 2013
  1. I. Abu Hashim, T. Higashi, T. Anno, K. Motoyama, A. Abd-ElGawad, M. El-Shabouri, T. Borg and H. Arima. Potential use of γ-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin. International Journal of Pharmaceutics 392, 83–91 (2010). [CrossRef]
  2. A. Ahmed, A. Dashevsky and R. Bodmeier. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 75, 375–380 (2010). [CrossRef]
  3. M. Amidi, E. Mastrobattista, W. Jiskoot and W.E. Hennink. Chitosan-based delivery systems for protein therapeutics and antigens. Advanced Drug Delivery Reviews 62, 59–82 (2010). [CrossRef] [PubMed]
  4. G. Crini, P.M. Badot and E. Guibal. Chitine et Chitosane: Du biopolymère à l'application. Presses universitaires de Franche-Comté.
  5. T. Adali and E. Yilmaz. Synthesis, characterization and biocompatibility studies on chitosan-graft-poly (EGDMA). Carbohydrate Polymers 77, 136–141 (2009). [CrossRef]
  6. S.R. Van Tomme, G. Storm and W.E. Hennink. In situ gelling hydrogels for pharmaceutical and biomedical applications. International Journal of Pharmaceutics 355, 1–18 (2008). [CrossRef]
  7. A. Chenite, C. Chaput, D. Wang, C. Combes, M.D. Buschmann, C.D. Hoemann, J.C Leroux, B.L. Atkinson, F. Binette and A. Selmani. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21, 2155–2161 (2000). [CrossRef]
  8. S.A. Agnihotri, N.N. Mallikarjuna, T.M. Aminabhavi. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. Journal of Controlled Release 100, 5–28 (2004). [CrossRef]
  9. S. Kim, S. K. Nishimoto, J. D. Bumgardner, W. O. Haggard, M. W Gaber, Y , Yang. A chitosan/b-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 31, 4157–4166 (2010). [CrossRef]